FDA approves new type of PSA testing methodology

  In January 2019, the FDA approved the “finger-prick” Sangia Total PSA blood test developed by OPKO Diagnostics. It seems likely that many urology practices will be interested in using a method like this for PSA testing over the next couple of years, since it will mean (effectively) instant access to patients’ PSA data at the time of their regular visits...Read More